| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.10▲ | 3.10▲ | 3.10▲ | 3.13▼ | 2.80▲ |
| MA10 | 3.07▲ | 3.07▲ | 3.07▲ | 2.97▲ | 2.54▲ |
| MA20 | 3.05▲ | 3.08▲ | 3.10▲ | 2.68▲ | 2.45▲ |
| MA50 | 3.04▲ | 2.88▲ | 2.78▲ | 2.45▲ | 2.95▲ |
| MA100 | 2.73▲ | 2.56▲ | 2.49▲ | 2.47▲ | 3.43▼ |
| MA200 | 2.55▲ | 2.44▲ | 2.39▲ | 3.00▲ | 4.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.010▼ | -0.018▼ | 0.063▲ | 0.129▲ |
| RSI | 61.246▲ | 60.331▲ | 62.082▲ | 62.528▲ | 55.088▲ |
| STOCH | 81.655▲ | 78.394 | 71.901 | 73.609 | 64.404 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -27.907 | -23.377▲ |
| CCI | 204.020▲ | 179.294▲ | 156.108▲ | 81.814 | 181.059▲ |
|
Friday, March 13, 2026 04:02 AM
Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat cancers ...
|
|
Thursday, December 11, 2025 09:11 AM
Urges Stockholders Who Have Not Voted To Get Votes In FRAMINGHAM, MA / ACCESS Newswire / December 11, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical ...
|
|
Friday, November 21, 2025 02:35 PM
FRAMINGHAM, MA / ACCESS Newswire / November 19, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/03/26 | 3.30 | 3.30 | 2.9748 | 3.13 | 11,666 |
| 20/03/26 | 3.02 | 3.26 | 2.96 | 3.26 | 33,905 |
| 19/03/26 | 3.12 | 3.15 | 2.9201 | 3.03 | 8,473 |
| 18/03/26 | 3.13 | 3.13 | 2.93 | 3.12 | 22,350 |
| 17/03/26 | 3.24 | 3.28 | 2.8201 | 3.12 | 42,168 |
| 16/03/26 | 2.88 | 3.49 | 2.7708 | 3.38 | 116,940 |
| 13/03/26 | 2.89 | 2.89 | 2.59 | 2.8077 | 66,499 |
| 12/03/26 | 2.67 | 2.67 | 2.51 | 2.565 | 28,569 |
| 11/03/26 | 2.65 | 2.65 | 2.47 | 2.63 | 14,936 |
| 10/03/26 | 2.4259 | 2.65 | 2.42 | 2.64 | 106,154 |
|
|
||||
|
|
||||
|
|